These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34231695)

  • 1. The Butantan Institute and the Brazilian AntiCOVID Vaccine.
    Guimarães R
    Cien Saude Colet; 2021 Jul; 26(7):2829-2832. PubMed ID: 34231695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine.
    Precioso AR; Palacios R; Thomé B; Mondini G; Braga P; Kalil J
    Vaccine; 2015 Dec; 33(50):7121-5. PubMed ID: 26458796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Instituto Butantan and Instituto Clodomiro Picado: A long-standing partnership in science, technology, and public health.
    Gutiérrez JM; Teixeira CFP; Fan HW
    Toxicon; 2021 Oct; 202():75-81. PubMed ID: 34562498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacovigilance capacity strengthening for WHO prequalification: The case of the trivalent influenza vaccine manufactured by Instituto Butantan.
    Koike ME; Gattás VL; Lucchesi MBB; Moura de Oliveira MM; Vanni T; Thomé BDC; Menang O; Socquet M; Precioso AR
    Vaccine; 2019 Dec; 37(52):7560-7565. PubMed ID: 31590933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct from the COVID-19 crisis: research and innovation sparks in Brazil.
    Rosa MFF; da Silva EN; Pacheco C; Diógenes MVP; Millett C; Gadelha CAG; Santos LMP
    Health Res Policy Syst; 2021 Jan; 19(1):10. PubMed ID: 33478499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial.
    Kallas EG; Precioso AR; Palacios R; Thomé B; Braga PE; Vanni T; Campos LMA; Ferrari L; Mondini G; da Graça Salomão M; da Silva A; Espinola HM; do Prado Santos J; Santos CLS; Timenetsky MDCST; Miraglia JL; Gallina NMF; Weiskopf D; Sette A; Goulart R; Salles RT; Maestri A; Sallum AME; Farhat SCL; Sakita NK; Ferreira JCOA; Silveira CGT; Costa PR; Raw I; Whitehead SS; Durbin AP; Kalil J
    Lancet Infect Dis; 2020 Jul; 20(7):839-850. PubMed ID: 32220283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines: From Public Health to Big Business.
    Guimarães R
    Cien Saude Colet; 2021 May; 26(5):1847-1852. PubMed ID: 34076125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Human Hookworm Vaccine.
    Hotez PJ; Diemert D; Bacon KM; Beaumier C; Bethony JM; Bottazzi ME; Brooker S; Couto AR; Freire Mda S; Homma A; Lee BY; Loukas A; Loblack M; Morel CM; Oliveira RC; Russell PK
    Vaccine; 2013 Apr; 31 Suppl 2(Suppl 2):B227-32. PubMed ID: 23598487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost of production of live attenuated dengue vaccines: a case study of the Instituto Butantan, Sao Paulo, Brazil.
    Mahoney RT; Francis DP; Frazatti-Gallina NM; Precioso AR; Raw I; Watler P; Whitehead P; Whitehead SS
    Vaccine; 2012 Jul; 30(32):4892-6. PubMed ID: 22406455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer.
    Miyaki C; Meros M; Precioso AR; Raw I
    Vaccine; 2011 Jul; 29 Suppl 1():A12-5. PubMed ID: 21684420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemistry, manufacturing and control (CMC) and clinical trial technical support for influenza vaccine manufacturers.
    Wahid R; Holt R; Hjorth R; Berlanda Scorza F
    Vaccine; 2016 Oct; 34(45):5430-5435. PubMed ID: 27484011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
    Walwyn DR; Nkolele AT
    Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oswaldo Cruz Institute and its relationship with other biomedical research centers in São Paulo.
    Teixeira LA
    Parassitologia; 2005 Dec; 47(3-4):345-51. PubMed ID: 16866040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.
    Magnani DM; Silveira CGT; Ricciardi MJ; Gonzalez-Nieto L; Pedreño-Lopez N; Bailey VK; Gutman MJ; Maxwell HS; Domingues A; Costa PR; Ferrari L; Goulart R; Martins MA; Martinez-Navio JM; Fuchs SP; Kalil J; Timenetsky MDC; Wrammert J; Whitehead SS; Burton DR; Desrosiers RC; Kallas EG; Watkins DI
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28878078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Brazilian vaccine manufacturers' perspective and its current status.
    Homma A
    Biologicals; 2009 Jun; 37(3):173-6. PubMed ID: 19423359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical review of clinical vaccine studies at Oswaldo Cruz Institute and Oswaldo Cruz Foundation--technological development issues.
    Martins Rde M; Possas Cde A; Homma A
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):114-24. PubMed ID: 25742271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort studies to evaluate the safety and immunogenicity of the 2013, 2014, and 2015 seasonal influenza vaccines produced by Instituto Butantan.
    Mondini G; Braga PE; Lopes MH; Sartori AMC; Miyaji KT; Infante V; Randi BA; Timenetsky MDCST; Ferreira JCOA; Sakita NK; Precioso AR
    Rev Inst Med Trop Sao Paulo; 2018 Jul; 60():e37. PubMed ID: 30066805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The small pox vaccine: its first century in Brazil (from the Jennerian to the animal vaccine)].
    Fernandes T
    Hist Cienc Saude Manguinhos; 1999; 6(1):29-51. PubMed ID: 11625535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b.
    Martins Rde M; Camacho LA; Marcovistz R; Noronha TG; Maia Mde L; dos Santos EM; Barbosa GG; Silva AM; Souza PC; Lemos MC; Homma A
    Mem Inst Oswaldo Cruz; 2008 Nov; 103(7):711-8. PubMed ID: 19057823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The 60th anniversary of institute for animal vaccine production].
    VOSS JA
    Tidsskr Nor Laegeforen; 1952 Apr; 72(7):198. PubMed ID: 14950828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.